Surfactant replacement therapy (SRT) plays a pivotal role in the management of neonates
with respiratory distress syndrome (RDS) because it improves survival and reduces …

Meconium aspiration syndrome is a clinical condition characterized by respiratory failure
occurring in neonates born through meconium-stained amniotic fluid. Worldwide, the …

As management of respiratory distress syndrome (RDS) advances, clinicians must
continually revise their current practice. We report the fourth update of “European Guidelines …

Respiratory distress syndrome (RDS) care pathways evolve slowly as new evidence
emerges. We report the sixth version of “European Guidelines for the Management of RDS” …

Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …

Key points Respiratory distress is a common presenting feature among newborn infants.
Prompt investigation to ascertain the underlying diagnosis and appropriate subsequent …

Infants born through meconium-stained amniotic fluid (MSAF) are 100 times more likely than
infants born through clear amniotic fluid to develop respiratory distress in the neonatal …

Neonatal extracorporeal membrane oxygenation (ECMO) is a life-saving procedure for
critically ill neonates suffering from a potentially reversible disease, causing severe cardiac …

Objective CHF5633 (Chiesi Farmaceutici SpA, Parma, Italy) is the first fully synthetic
surfactant enriched by peptide analogues of two human surfactant proteins. We planned to …

Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy for patients with
respiratory and cardiac failure refractory to maximal medical management. The …